Correction to: Gr-MDSC-linked asset as a potential immune biomarker in pretreated NSCLC receiving nivolumab as second-line therapy.
Journal
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
ISSN: 1699-3055
Titre abrégé: Clin Transl Oncol
Pays: Italy
ID NLM: 101247119
Informations de publication
Date de publication:
04 2020
04 2020
Historique:
pubmed:
23
8
2019
medline:
23
8
2019
entrez:
22
8
2019
Statut:
ppublish
Résumé
Acknowledgements section was missing.
Identifiants
pubmed: 31432394
doi: 10.1007/s12094-019-02198-5
pii: 10.1007/s12094-019-02198-5
doi:
Types de publication
Journal Article
Published Erratum
Langues
eng
Sous-ensembles de citation
IM
Pagination
621Commentaires et corrections
Type : ErratumFor